Privia Health Group (PRVA) Competitors $19.51 -0.27 (-1.37%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$19.64 +0.13 (+0.65%) As of 08:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRVA vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, WGS, ADUS, and PGNYShould you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), GeneDx (WGS), Addus HomeCare (ADUS), and Progyny (PGNY). These companies are all part of the "healthcare" industry. Privia Health Group vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent GeneDx Addus HomeCare Progyny Privia Health Group (NASDAQ:PRVA) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends. Do analysts rate PRVA or GH? Privia Health Group currently has a consensus price target of $28.38, indicating a potential upside of 45.49%. Guardant Health has a consensus price target of $57.50, indicating a potential upside of 14.11%. Given Privia Health Group's higher probable upside, equities research analysts plainly believe Privia Health Group is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Privia Health Group 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.00Guardant Health 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 3.06 Which has higher earnings and valuation, PRVA or GH? Privia Health Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrivia Health Group$1.80B1.32$14.39M$0.12162.58Guardant Health$739.02M8.50-$436.37M-$3.35-15.04 Is PRVA or GH more profitable? Privia Health Group has a net margin of 0.87% compared to Guardant Health's net margin of -49.93%. Privia Health Group's return on equity of 2.32% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Privia Health Group0.87% 2.32% 1.38% Guardant Health -49.93%N/A -28.95% Do insiders & institutionals have more ownership in PRVA or GH? 94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 10.7% of Privia Health Group shares are owned by insiders. Comparatively, 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer PRVA or GH? In the previous week, Guardant Health had 3 more articles in the media than Privia Health Group. MarketBeat recorded 13 mentions for Guardant Health and 10 mentions for Privia Health Group. Guardant Health's average media sentiment score of 0.80 beat Privia Health Group's score of 0.32 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, PRVA or GH? Privia Health Group has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. SummaryPrivia Health Group beats Guardant Health on 10 of the 16 factors compared between the two stocks. Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRVA vs. The Competition Export to ExcelMetricPrivia Health GroupMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.41B$1.99B$5.48B$9.56BDividend YieldN/AN/A3.99%4.17%P/E Ratio162.6034.4029.9325.14Price / Sales1.3248.98375.2276.13Price / Cash109.6250.3435.9458.58Price / Book3.429.088.105.59Net Income$14.39M-$63.67M$3.26B$265.48M7 Day Performance3.45%1.36%0.68%1.22%1 Month Performance-9.34%-0.62%2.45%0.39%1 Year Performance0.83%19.27%27.72%23.47% Privia Health Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRVAPrivia Health Group3.7698 of 5 stars$19.51-1.4%$28.38+45.5%+6.8%$2.41B$1.80B162.601,140News CoverageHigh Trading VolumeGHGuardant Health3.5137 of 5 stars$44.27-0.3%$54.45+23.0%+48.4%$5.50B$774.00M-13.062,021Gap UpOPCHOption Care Health4.6179 of 5 stars$29.77+0.3%$35.50+19.2%-4.6%$4.86B$5.19B24.018,088RDNTRadNet4.0768 of 5 stars$57.83+0.7%$69.60+20.4%-7.7%$4.31B$1.83B-134.4911,021Positive NewsUpcoming EarningsGap UpBTSGBrightSpring Health Services2.0567 of 5 stars$20.48-0.2%$24.90+21.6%+82.0%$3.61B$11.27B73.1435,000Earnings ReportAnalyst RevisionSHCSotera Health2.6335 of 5 stars$12.29-0.1%$16.00+30.2%-22.0%$3.49B$1.10B153.643,000News CoverageSGRYSurgery Partners2.8228 of 5 stars$22.44+5.6%$33.33+48.5%-18.8%$2.72B$3.11B-14.6715,000Earnings ReportCONConcentra Group Holdings Parent3.0666 of 5 stars$20.05+2.0%$28.50+42.1%-8.5%$2.52B$1.90B14.9611,250News CoverageEarnings ReportWGSGeneDx3.0748 of 5 stars$84.91+6.4%$92.33+8.7%+264.1%$2.28B$305.45M-60.221,200High Trading VolumeADUSAddus HomeCare4.9054 of 5 stars$109.11-0.3%$142.57+30.7%-10.7%$2.01B$1.15B24.6349,703News CoverageEarnings ReportAnalyst ForecastPGNYProgyny1.1525 of 5 stars$23.20+0.4%$24.82+7.0%+10.6%$1.98B$1.17B40.70310Positive NewsEarnings Report Related Companies and Tools Related Companies GH Competitors OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors SGRY Competitors CON Competitors WGS Competitors ADUS Competitors PGNY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRVA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
